{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:03:51Z","timestamp":1776359031722,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902985"],"award-info":[{"award-number":["81902985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973170"],"award-info":[{"award-number":["81973170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273777"],"award-info":[{"award-number":["82273777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bioorg.2022.106318","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T10:59:27Z","timestamp":1670669967000},"page":"106318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Design, synthesis, and evaluation of JTE-013 derivatives as novel potent S1PR2 antagonists for recovering the sensitivity of colorectal cancer to 5-fluorouracil"],"prefix":"10.1016","volume":"131","author":[{"given":"Zhikun","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuecui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengbiao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bioorg.2022.106318_b0005","doi-asserted-by":"crossref","first-page":"14839","DOI":"10.1074\/jbc.M112.426726","article-title":"Sphingosine 1-Phosphate (S1P) Receptor Agonists Mediate Pro-fibrotic Responses in Normal Human Lung Fibroblasts via S1P2 and S1P3 Receptors and Smad-independent Signaling","volume":"288","author":"Sobel","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2022.106318_b0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cellsig.2018.09.019","article-title":"S1PR2 Antagonist Alleviates Oxidative Stress-enhanced Brain Endothelial Permeability by Attenuating p38 and Erk1\/2-Dependent cPLA2 Phosphorylation","volume":"53","author":"Cao","year":"2019","journal-title":"Cell Signal"},{"key":"10.1016\/j.bioorg.2022.106318_b0015","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1182\/blood-2016-01-692129","article-title":"S1PR2 Deficiency in DLBCL: a FOXy Connection","volume":"127","author":"Baldari","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2022.106318_b0020","doi-asserted-by":"crossref","first-page":"eaav1263","DOI":"10.1126\/sciimmunol.aav1263","article-title":"CD4 T Cell Sphingosine 1-Phosphate Receptor (S1PR)1 and S1PR4 and Endothelial S1PR2 Regulate Afferent Lymphatic Migration","volume":"4","author":"Xiong","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bioorg.2022.106318_b0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood-2012-11-467191","article-title":"Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation","volume":"122","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2022.106318_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104717","article-title":"S1PR2 Inhibitors Potently Reverse 5-FU Resistance by Downregulating DPD Expression in Colorectal Cancer","volume":"155","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2022.106318_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113775","article-title":"Design, Synthesis and Biological Evaluation of Sphingosine-1-Phosphate Receptor 2 Antagonists as Potent 5-FU-resistance reversal agents for the treatment of colorectal cancer","volume":"225","author":"Luo","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106318_b0040","article-title":"Novel 5-Fluorouracil Sensitizers for Colorectal Cancer Therapy: Design and Synthesis of S1P Receptor 2 (S1PR2) Antagonists","volume":"227","author":"Luo","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106318_b0045","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules13081551","article-title":"5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies","volume":"13","author":"Zhang","year":"2008","journal-title":"Molecules"},{"issue":"Suppl 10","key":"10.1016\/j.bioorg.2022.106318_b0050","doi-asserted-by":"crossref","first-page":"x71","DOI":"10.1093\/annonc\/mds354","article-title":"Current stages of adjuvant treatment of colon cancer","volume":"23","author":"Kohne","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioorg.2022.106318_b0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2022.106318_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-Fluorouracil and Other Fluoropyrimidines in Colorectal Cancer: Past, Present and Future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2022.106318_b0065","first-page":"23","article-title":"The Role of Dihydropyrimidine Dehydrogenase (DPD) Modulation in 5-FU Pharmacology","volume":"12","author":"Diasio","year":"1998","journal-title":"Oncol. (Williston Park)"},{"key":"10.1016\/j.bioorg.2022.106318_b0070","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/cancers2031717","article-title":"5-Fu Metabolism in Cancer and Orally-administrable 5-Fu Drugs","volume":"2","author":"Miura","year":"2010","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2022.106318_b0075","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0959-8049(02)00048-5","article-title":"Enhancement of the Antitumour Activity of 5-Fluorouracil (5-FU) by Inhibiting Dihydropyrimidine Dehydrogenase activity (DPD) using 5-Chloro-2,4-dihydroxypyridine (CDHP) in Human Tumour Cells","volume":"38","author":"Takechi","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioorg.2022.106318_b0080","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bmcl.2016.01.031","article-title":"Discovery of Novel S1P2 Antagonists, Part 3: Improving the Oral Bioavailability of a Series of 1,3-Bis(aryloxy)benzene Derivatives","volume":"26","author":"Kusumi","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106318_b0085","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1016\/j.bmcl.2015.09.022","article-title":"Discovery of Novel S1P2 Antagonists. Part 2: improving the Profile of a Series of 1,3-Bis(aryloxy)benzene Derivatives","volume":"25","author":"Kusumi","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.bioorg.2022.106318_b0090","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bmcl.2015.02.029","article-title":"Discovery of Novel S1P2 Antagonists. Part 1: discovery of 1,3-Bis(aryloxy)benzene Derivatives","volume":"25","author":"Kusumi","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"17","key":"10.1016\/j.bioorg.2022.106318_b0095","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.bmc.2013.06.012","article-title":"A sphingosine 1-Phosphate Receptor 2 selective allosteric agonist","volume":"21","author":"Satsu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2022.106318_b0100","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1021\/acs.jmedchem.1c00138","article-title":"Brys, Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoro methyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a preclinical candidate for the treatment of idiopathic pulmonary fibrosis","volume":"64","author":"Mammoliti","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106318_b0105","doi-asserted-by":"crossref","first-page":"14557","DOI":"10.1021\/acs.jmedchem.1c01066","article-title":"Brys, Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases","volume":"64","author":"Mammoliti","year":"2021","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2022.106318_b0110","doi-asserted-by":"crossref","first-page":"eabn0067","DOI":"10.1126\/sciadv.abn0067","article-title":"Structure of S1PR2\u2013heterotrimeric G13 Signaling Complex","volume":"8","author":"Chen","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2022.106318_b0115","unstructured":"Preparation of Pyrazolopyridine Compounds and Use Thereof as Remedies for Fibrosis. WO 2001098301A1, 2001."},{"key":"10.1016\/j.bioorg.2022.106318_b0120","unstructured":"Bicyclic Compounds for Treatment of Inflammatory or Allergic Conditions and their Preparation. WO2008107436A1, 2008."},{"key":"10.1016\/j.bioorg.2022.106318_b0125","unstructured":"Preparation of Phenyl Derivatives as S1P2 Receptor Antagonists. WO 2013047701A1, 2013."},{"key":"10.1016\/j.bioorg.2022.106318_b0130","unstructured":"Pyridinone- and Pyridazinone-based Compounds and Medical Uses Thereof. WO 2019173790A1, 2019."},{"key":"10.1016\/j.bioorg.2022.106318_b0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and Ligand Preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2022.106318_b0140","unstructured":"Schr\u00f6dinger Release2021-4: Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2021; Impact, Schr\u00f6dinger."},{"key":"10.1016\/j.bioorg.2022.106318_b0145","unstructured":"Schr\u00f6dinger Release2021-4: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2021. Maestro-Desmond."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822007258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822007258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:41:01Z","timestamp":1758616861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822007258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":29,"alternative-id":["S0045206822007258"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106318","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of JTE-013 derivatives as novel potent S1PR2 antagonists for recovering the sensitivity of colorectal cancer to 5-fluorouracil","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106318"}}